Hospira Buprenorphine Hydrochloride Injection and Labetalol Hydrochloride Injection - recalled due to Packaging Defect, USA
4 months ago •source fda.gov • details
Recall notice
Updated:
Recent Reports
4 months ago •source fda.gov • details
Recall notice
2 years ago •reported by user-zbzw3982 • details
2 years ago •source fda.gov • details
Recall notice
2 years ago •source fda.gov • details
Recall notice
2 years ago •source fda.gov • details
Recall notice
2 years ago •reported by user-vmznv149 • details
2 years ago •reported by user-fhcpz312 • details
2 years ago •reported by user-tndyp932 • details
2 years ago •reported by user-tfqg1117 • details
2 years ago •reported by user-rwzyw489 • details
Search